Related references
Note: Only part of the references are listed.A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Meriem Messaoudene et al.
CANCER DISCOVERY (2022)
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A. McCulloch et al.
NATURE MEDICINE (2022)
Unraveling city-specific signature and identifying sample origin locations for the data from CAMDA MetaSUB challenge
Runzhi Zhang et al.
BIOLOGY DIRECT (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
Gladys Ferrere et al.
JCI INSIGHT (2021)
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Fyza Y. Shaikh et al.
CLINICAL CANCER RESEARCH (2021)
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer et al.
SCIENCE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country
Jacky Dwiyanto et al.
SCIENTIFIC REPORTS (2021)
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He et al.
CELL METABOLISM (2021)
Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Maria Tsikala-Vafea et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Energy status dictates PD-L1 protein abundance and anti-tumor to enable blockade
Xiaoming Dai et al.
MOLECULAR CELL (2021)
Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora et al.
NATURE (2021)
Gut-microbiota-targeted diets modulate human immune status
Hannah C. Wastyk et al.
CELL (2021)
Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma
Karisa C. Schreck et al.
NEUROLOGY (2021)
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Matthew E. Griffin et al.
SCIENCE (2021)
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu et al.
NATURE COMMUNICATIONS (2021)
Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells
Louise Dupraz et al.
CELL REPORTS (2021)
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Chirayu Mohindroo et al.
CANCER MEDICINE (2021)
Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen
Vancheswaran Gopalakrishnan et al.
MICROORGANISMS (2021)
Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma
Karisa C. Schreck et al.
NEUROLOGY (2021)
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
Shi-Long Zhang et al.
THERANOSTICS (2021)
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer
Nadina Tinsley et al.
ONCOLOGIST (2020)
Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study
Adeleh Khodabakhshi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2020)
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
Mireia Uribe-Herranz et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Andrea Botticelli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Candice R. Gurbatri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth
Yan Li et al.
CELL REPORTS (2020)
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells
Qi Yan Ang et al.
CELL (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy.
Yinghong Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
Aadra P. Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Maria Paula Roberti et al.
NATURE MEDICINE (2020)
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Adrienne M. Luoma et al.
CELL (2020)
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
Martin Voss et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Catherine A. Bessell et al.
JCI INSIGHT (2020)
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
Motoo Nomura et al.
JAMA NETWORK OPEN (2020)
An intact gut microbiome protects genetically predisposed mice against leukemia
Carolina Vicente-Duenas et al.
BLOOD (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients
Rainer J. Klement et al.
BREAST CANCER RESEARCH (2020)
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Tingting Wang et al.
NATURE METABOLISM (2020)
Analysis of 1321 Eubacterium rectale genomes from metagenomes uncovers complex phylogeographic population structure and subspecies functional adaptations
Nicolai Karcher et al.
GENOME BIOLOGY (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue
Emily L. Goldberg et al.
NATURE METABOLISM (2020)
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Chengcheng Jin et al.
CELL (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
Delphine L. Laute-Caly et al.
SCIENTIFIC REPORTS (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas et al.
NATURE MEDICINE (2019)
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
Jakob Wirbel et al.
NATURE MEDICINE (2019)
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice
Yan Li et al.
NATURE COMMUNICATIONS (2019)
Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells
Annabel Bachem et al.
IMMUNITY (2019)
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Sreyan Chowdhury et al.
NATURE MEDICINE (2019)
Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
Eduard Ansaldo et al.
SCIENCE (2019)
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Karthik Suresh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients
Xuan-Zhang Huang et al.
ONCOIMMUNOLOGY (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
1249PAssociation of SCFA in gut microbiome and clinical response in solid cancer patients treated with andi-PD-1 antibody
M Nomura et al.
ANNALS OF ONCOLOGY (2019)
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
Brandilyn A. Peters et al.
GENOME MEDICINE (2019)
Antibiotic therapy and outcome from immune-checkpoint inhibitors
David J. Pinato et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle
Edoardo Pasolli et al.
CELL (2019)
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma
Pok Fai Wong et al.
CLINICAL CANCER RESEARCH (2019)
Microbiota and cancer immunotherapy: in search of microbial signals
Raad Z. Gharaibeh et al.
GUT (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
Marlies Meisel et al.
NATURE (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Do immune checkpoint inhibitors need new studies methodology?
Roberto Ferrara et al.
JOURNAL OF THORACIC DISEASE (2018)
Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (accRCC): Results from cohort A of KEYNOTE-427.
David F. McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Mo Xu et al.
NATURE (2018)
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases
Valentino Le Noci et al.
CELL REPORTS (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Gut microbiota diversity across ethnicities in the United States
Andrew W. Brooks et al.
PLOS BIOLOGY (2018)
Microbial strain-level population structure and genetic diversity from metagenomes
Duy Tin Truong et al.
GENOME RESEARCH (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials
Amir Zahra et al.
RADIATION RESEARCH (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman et al.
SCIENCE (2017)
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T cells
Meike Kespohl et al.
FRONTIERS IN IMMUNOLOGY (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation
Jiani N. Chai et al.
SCIENCE IMMUNOLOGY (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Cloning, characterization, and production of three -l-fucosidases from Clostridium perfringens ATCC 13124
Shuquan Fan et al.
JOURNAL OF BASIC MICROBIOLOGY (2016)
Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet
Danielle M. Lussier et al.
BMC CANCER (2016)
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillere et al.
IMMUNITY (2016)
Chronically Elevated Levels of Short-Chain Fatty Acids Induce T Cell-Mediated Ureteritis and Hydronephrosis
Jeongho Park et al.
JOURNAL OF IMMUNOLOGY (2016)
Metabolomic Modeling To Monitor Host Responsiveness to Gut Microbiota Manipulation in the BTBRT+tf/j Mouse
Matthias S. Klein et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2016)
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Yusuke Shono et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
Christopher Staley et al.
MBIO (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder
Christopher Newell et al.
MOLECULAR AUTISM (2016)
Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle
Anastassia Gorvitovskaia et al.
MICROBIOME (2016)
Purinergic regulation of the immune system
Caglar Cekic et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R. Jenq et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors
Sumanta K. Pal et al.
CLINICAL CANCER RESEARCH (2015)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine
Magdalena Frank et al.
JOURNAL OF IMMUNOLOGY (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway
J. Park et al.
MUCOSAL IMMUNOLOGY (2015)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Rethinking Enterotypes
Dan Knights et al.
CELL HOST & MICROBE (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Focused specificity of intestinal TH17 cells towards commensal bacterial antigens
Yi Yang et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
Aurelien Trompette et al.
NATURE MEDICINE (2014)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Julien Fourcade et al.
CANCER RESEARCH (2012)
Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Ying Taur et al.
CLINICAL INFECTIOUS DISEASES (2012)
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R. Jenq et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen
Akinobu Kurita et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Diet, gut microbiota and immune responses
Kendle M. Maslowski et al.
NATURE IMMUNOLOGY (2011)
Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes
Christopher W. Kaplan et al.
INFECTION AND IMMUNITY (2010)
Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis
Nicole R. Luke et al.
INFECTION AND IMMUNITY (2010)
Human colonic microbiota associated with diet, obesity and weight loss
S. H. Duncan et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Primary gastrointestinal non-Hodgkin's lymphoma:: II.: Combined surgical and conservative or conservative management only in localized gastric lymphoma -: Results of the Prospective German Multicenter Study GIT NHL 01/92
P Koch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
